Your session is about to expire
← Back to Search
Remote Ischemic Preconditioning for Heart Failure (RICH Trial)
RICH Trial Summary
This trial is studying whether a treatment called remote ischemic preconditioning can reduce contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.
RICH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRICH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RICH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I require dialysis for my kidney condition.You have a high risk of developing acute kidney injury according to the SCAI score.I have had a kidney transplant.Your blood pressure is very high (over 200) or very low (under 80) when you join the study.I am unable to understand and agree to the study's details.I have been exposed to contrast dye within the last 3 days before my heart imaging test.I am referred for a procedure to check or unblock my heart's arteries.I may have stable heart disease or a recent heart problem.I have poor blood flow in my arm's arteries.You do not have at least one arm available for a certain type of treatment.I am 18 years old or older.My heart's pumping ability is reduced (LVEF <50%).I am restricted from receiving normal saline IV fluids before a procedure.
- Group 1: Remote ischemic preconditioning
- Group 2: Sham remote ischemic preconditioning
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are taking part in this clinical research?
"The most recent information on clinicaltrials.gov says that this trial is still recruiting patients. The posting date was 11/1/2021, and the last update occurred on 11/2/2022. There are plans to enroll 240 participants at 2 locations."
Are we currently looking for new participants in this clinical trial?
"This research project is still recruiting test subjects, with the first posting on clinicaltrials.gov being November 1st, 2021 and the most recent update coming on November 2nd, 2022."
Who else is applying?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger